Drug discovery and development are intricate processes that traditionally involve numerous costly and time-consuming experimental steps. AI has emerged as a game-changer in this domain, offering a suite of tools and techniques that can significantly expedite the drug design process while reducing costs and enhancing success rates. AI-aided drug design leverages machine learning algorithms, deep learning models, molecular simulations, and big data analytics to streamline various stages of drug discovery, from target identification to lead optimization and pharmacokinetics evaluation. https://ai.computabio.com/...

Only people mentioned by VivianSmith in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vivian Smith, click on at the bottom under it